| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/01/2003 | CN1387905A Orally taken fracture setting Chinese medicine |
| 01/01/2003 | CN1387899A Externally applied ointment for treating burns and its prepn |
| 01/01/2003 | CN1387887A Chinese medicine prepn for treating arterioscleriosis |
| 01/01/2003 | CN1387886A Chinese medicine prepn for treating lupus erythematosus |
| 01/01/2003 | CN1387884A Chinese herbal medicine for treating No.5 disease of livestock |
| 01/01/2003 | CN1387882A Chinese medicine prepn for treating cervical spondylopathy and its prepn process |
| 01/01/2003 | CN1387881A Externally applied Chinese medicine oil prepn for treating burns and scalds |
| 01/01/2003 | CN1387880A Blood circulation promoting wine |
| 01/01/2003 | CN1387879A Fase nursing and beautifying oral liquid and its prepn |
| 01/01/2003 | CN1387875A Recipe and prepn process of spleen and kidney invigorating medicine |
| 01/01/2003 | CN1387873A Medicine for treating tumor in digestive tract and its prepn |
| 01/01/2003 | CN1387866A Konjaku capsule for treating type-II diabetes |
| 01/01/2003 | CN1387864A Medicine for treating stomatocase and throat ache and its prepn |
| 01/01/2003 | CN1387863A Prepn process and use of heat-resisting nutritious microcapsule fish oil DHA powder |
| 01/01/2003 | CN1387862A Prepn of leukemia treating medicine with internal organs of scallop |
| 01/01/2003 | CN1387861A Yunnan Heiyao and its application in treating tumors |
| 01/01/2003 | CN1387860A Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases |
| 01/01/2003 | CN1387840A Prepn of superfine instant chinese medicine granule |
| 01/01/2003 | CN1387796A Organic-state Chinese medicinal stone essence and its production process |
| 01/01/2003 | CN1097464C Chinese herbal medicine for treating cervical or lumbar vertebra diseases |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500468 Panax notoginsenoside composition |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500463 Mixing plasticizable matrix material, liquid plasticizer, encapsulant, non-plasticizable non-gelatinized starch, and component for controlling rate of release of encapsulant under low shear and low temperature, forming into pieces, drying |
| 12/31/2002 | US6500438 In ovo vaccination against coccidiosis |
| 12/31/2002 | US6500436 Administering botulinium toxin component coupled to substance p |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3) |
| 12/31/2002 | US6500421 Combination of the antifolate and the nucleoside transport inhibitor selects in vivo for the genetically modified hematopoietic progenitor cells |
| 12/31/2002 | US6500419 Method for introducing and expressing RNA in animal cells |
| 12/31/2002 | CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine |
| 12/28/2002 | CA2351805A1 A method of manufacturing a pill medicine for killing spirilla |
| 12/27/2002 | WO2002103034A1 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | WO2002102994A2 Human secreted proteins |
| 12/27/2002 | WO2002102993A2 Human secreted proteins |
| 12/27/2002 | WO2002102989A2 Method for neural stem cell differentiation using valproate |
| 12/27/2002 | WO2002102988A2 Method for neural stem cell differentiation using 5ht-1a agonists |
| 12/27/2002 | WO2002102971A2 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 12/27/2002 | WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | WO2002102837A2 Marker for identifying hematopoietic stem cells |
| 12/27/2002 | WO2002102828A2 Chimeric flavivirus vectors |
| 12/27/2002 | WO2002102722A1 Medical grade water production system |
| 12/27/2002 | WO2002102406A1 Use of glycoprotein for the treatment and re-epithelialisation of wounds |
| 12/27/2002 | WO2002102400A1 Use of macrocyclic peptide compound as anticancer agents and method for diagnosing cancer |
| 12/27/2002 | WO2002102397A1 Use of an extract of the root of balloon-flower for preventing and treating a degenerative brain disease or for enhancing memory |
| 12/27/2002 | WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | WO2002102305A2 Adjuvant composition for mucosal and injection delivered vaccines |
| 12/27/2002 | WO2002088330A3 Neural progenitor cells |
| 12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
| 12/27/2002 | WO2002072144A9 Remedies for nerve damages |
| 12/27/2002 | WO2002069989A3 Aquatic animal treatment method and composition containing pimenta extract |
| 12/27/2002 | WO2002066620A3 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 12/27/2002 | WO2002057415A3 Method for altering cell fate |
| 12/27/2002 | WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals |
| 12/27/2002 | WO2002056907A3 Molecular antigen array presenting amyloid beta |
| 12/27/2002 | WO2002051994A3 Polypeptides |
| 12/27/2002 | WO2002047612A3 Dietary supplement compositions |
| 12/27/2002 | WO2002029065A3 Retroviral vectors containing internal ribosomal entry sites |
| 12/27/2002 | WO2002010379B1 Modified cea and uses thereof |
| 12/27/2002 | WO2002004623A3 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 12/27/2002 | WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/27/2002 | WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 12/27/2002 | WO2001083715A8 Derivation of midbrain dopaminergic neurons from embryonic stem cells |
| 12/27/2002 | WO2001080865A9 Joint repair using mesenchymal stem cells |
| 12/27/2002 | WO2001079300A9 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor |
| 12/27/2002 | WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof |
| 12/27/2002 | WO2001021767A9 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 12/27/2002 | WO2000052184A9 Anti-neoplastic compositions and uses thereof |
| 12/27/2002 | CA2456864A1 Adjuvant composition for mucosal and injection delivered vaccines |
| 12/27/2002 | CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | CA2450732A1 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | CA2450444A1 Method of selecting non-pathogenic gram-positive lactic acid bacteria strains |
| 12/27/2002 | CA2449910A1 Use of glycoprotein for the treatment and re-epithelialisation of wounds |
| 12/27/2002 | CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | CA2448971A1 Chimeric flavivirus vectors |
| 12/27/2002 | CA2441832A1 Human secreted proteins |
| 12/27/2002 | CA2441702A1 Human secreted proteins |
| 12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/26/2002 | US20020198510 Method for nasal application of a medicinal substance |
| 12/26/2002 | US20020198379 Active compound from a sponge |
| 12/26/2002 | US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence |
| 12/26/2002 | US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020197329 Conditioned media for inhibiting growth of tumor cells |
| 12/26/2002 | US20020197268 Allergen-containing milk for allergy treatment |
| 12/26/2002 | US20020197266 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 12/26/2002 | US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/26/2002 | US20020197242 Composition for filling bone defects |
| 12/26/2002 | US20020197241 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions |
| 12/26/2002 | US20020197240 Marrow stem cell (MSC) transplantation for use in tissue and/or organ repair |
| 12/26/2002 | US20020197239 Methods and devices for the long-culture of hematopoietic progenitor cells |
| 12/26/2002 | US20020197238 Platelet derived growth factor (PDGF)-derived neurospheres define a novel class of progenitor cells |
| 12/26/2002 | CA2391580A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one antifungal agent or at least one antibacterial agent |